Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q2 FY23 Earnings Concall dated Nov. 08, 2022 Corporate participants: Arvind Lal -- Executive Chairman Om Prakash
Dr Lal PathLabs Ltd (LALPATHLAB) Q2 FY23 Earnings ConCall Transcript
Categories
Healthcare
Max Healthcare Institute Ltd (MAXHEALTH) Q2 FY23 Earnings Concall Transcript
Max Healthcare Institute Ltd (NSE:MAXHEALTH) Q2 FY23 Earnings Concall dated Nov. 02, 2022 Corporate Participants: Suraj Digawalekar -- CDR India Investor Relations
Gland Pharma Limited (GLAND) Q2 FY23 Earnings Concall Transcript
Gland Pharma Limited (NSE:GLAND) Q2 FY23 Earnings Concall dated Oct. 26, 2022 Corporate Participants: Sumanta Bajpayee — Vice President, Corporate Finance and Investor Relations
Aarti Drugs Ltd. (AARTIDRUGS) Q2 FY23 Earnings Concall Transcript
Aarti Drugs Ltd. (NSE:AARTIDRUGS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Adhish P. Patil -- Chief Financial Officer Vishwa Savla -- Managing Director
Apollo Hospitals research report at a glimpse
Stock Data: TickerAPOLLOHOSPExchangeBSE and NSE IndustryHealthcare Why is the stock price rising? Shares of Apollo Hospitals Enterprise Ltd have gained 8.84% over the
Divi’s Laboratories Ltd (DIVISLAB) Q1 FY23 Earnings Concall Transcript
Divi's Laboratories Ltd (NSE:DIVISLAB) Q1 FY23 Earnings Concall dated Aug. 12, 2022 Corporate Participants: Satish Choudhury -- Company Secretary and Chief Investor
Nava Bharat Ventures Limited (NBVENTURES) Q1 FY23 Earnings Concall Transcript
Nava Bharat Ventures Limited (BSE: NBVENTURES) Q1 FY23 Earnings Concall dated Aug.12, 2022 Corporate Participants: Ashwin Devineni -- Chief Executive Officer Analysts: Mohit Kumar -- DAM
Hikal Limited (HIKAL) Q2 FY23 Earnings Concall Transcript
Hikal Limited (NSE:HIKAL) Q2 FY23 Earnings Concall dated Aug. 11, 2022 Corporate Participants: Sameer Hiremath -- Managing Director Manoj Mehrotra -- President-Pharmaceuticals Vimal
Orchid Pharma Ltd (ORCHPHARMA) Q1 FY23 Earnings Concall Transcript
Orchid Pharma Ltd (NSE:ORCHPHARMA) Q1 FY23 Earnings Concall dated Aug. 10, 2022 Corporate Participants: Mridul Dhanuka -- Executive Director Sunil Kumar Gupta --
Glenmark Life Sciences Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/02Igs_HUAfo Key highlights from Glenmark Life Sciences Limited (GLS) Q1 FY23 Earnings Concall Q&A Highlights: [00:14:56] Neha Manpuria from Bank of America
Rainbow Children’s Medicare Ltd (RAINBOW) Q2 FY23 Earnings Concall Transcript
Rainbow Children's Medicare Ltd (NSE:RAINBOW) Q2 FY23 Earnings Concall dated Aug. 09, 2022 Corporate Participants: Siddharth Rangnekar -- Investor Relations Ramesh Kancharla
Dr Lal PathLabs Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/GyHJJGLWdjg Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q1 FY23 Earnings Concall Management Update: LALPATHLAB said it clocked the highest quarterly
Sun Pharmaceutical Industries Ltd Q1 FY23 Earnings Conference Call Insights
Key highlights from Sun Pharmaceutical Industries Ltd (SUNPHARMA) Q1 FY23 Earnings Concall Management Update: SUNPHARMA recorded the highest ever quarterly revenue in
Dr Lal PathLabs Ltd (LALPATHLAB) Q1 FY23 Earnings Concall Transcript
Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q1 FY23 Earnings Concall dated Jul. 28, 2022 Corporate Participants: Arvind Lal -- Executive Chairman Om Prakash
Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Transcript
Gland Pharma Limited (NSE: GLAND) Q1 FY23 Earnings Concall dated Jul. 20, 2022 Corporate Participants: Sumanta Bajpayee -- Vice President, Corporate Finance and Investor
Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Transcript
Gland Pharma Limited (NSE:GLAND) Q1 FY23 Earnings Concall dated Jul. 20, 2022 Corporate Participants: Sumanta Bajpayee -- Vice President, Corporate Finance and Investor
Lupin Ltd Q4 FY22 Earnings Conference Call Insights
https://youtu.be/KuHcJgOThAg Key highlights from Lupin Ltd (LUPIN) Q4 FY22 Earnings Concall Q&A Highlights: Pritesh Vora - Mission Street India - Analyst
Apollo Hospitals Q4 FY22 Earnings Conference Call Insights
https://youtu.be/o39b8VAmN3k Key highlights from Apollo Hospitals (APOLLOHOSP) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal from Credit Suisse asked what impacted the
Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Transcript
Hikal Limited (NSE: HIKAL) Q4 FY22 Earnings Concall dated Jun. 03, 2022 Corporate Participants: Anish Swadi -- Senior President of Animal Health and Business
Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) Q4 FY22 Earnings Concall Transcript
Apollo Hospitals Enterprise Ltd. (NSE: APOLLOHOSP) Q4 FY22 Earnings Concall dated May 26, 2022 Corporate Participants: Mayank Vaswani -- Moderator Suneeta Reddy -- Managing Director Obul
Divi’s Laboratories Ltd. (DIVISLAB) Q4 FY22 Earnings Concall Transcript
Divi's Laboratories Ltd. (NSE: DIVISLAB) Q4 FY22 Earnings Concall dated May 23, 2022 Corporate Participants: Satish Choudhury -- Chief Investor Relations Officer Murali K.